WHITTIER TRUST CO - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$30,585
-19.2%
6740.0%0.00%0.0%
Q2 2023$37,830
+24.1%
6740.0%0.00%0.0%
Q1 2023$30,477
+11.2%
6740.0%0.00%0.0%
Q4 2022$27,397
+95.7%
674
+224.0%
0.00%
Q3 2022$14,000
+7.7%
2080.0%0.00%
Q2 2022$13,0000.0%2080.0%0.00%
Q1 2022$13,000
-13.3%
208
+4.5%
0.00%
Q4 2021$15,000
-88.1%
199
-82.3%
0.00%
-100.0%
Q3 2021$126,000
-30.8%
1,1230.0%0.00%
-33.3%
Q2 2021$182,000
+32.8%
1,1230.0%0.00%0.0%
Q1 2021$137,000
+356.7%
1,123
+464.3%
0.00%
+200.0%
Q4 2020$30,000
+76.5%
1990.0%0.00%
Q3 2020$17,000
+13.3%
1990.0%0.00%
Q2 2020$15,000
+87.5%
1990.0%0.00%
Q1 2020$8,000
-33.3%
1990.0%0.00%
Q4 2019$12,000
+50.0%
1990.0%0.00%
Q3 2019$8,000
-11.1%
1990.0%0.00%
Q2 2019$9,000
+28.6%
1990.0%0.00%
Q1 2019$7,000
+16.7%
1990.0%0.00%
Q4 2018$6,000
-33.3%
1990.0%0.00%
Q3 2018$9,000
-25.0%
1990.0%0.00%
Q2 2018$12,0001990.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 508,558$82,330,00027.28%
Valiant Capital Management, L.P. 307,700$49,814,0003.74%
NEA Management Company, LLC 1,590,002$257,405,0003.35%
NIA IMPACT ADVISORS, LLC 39,891$6,458,0003.15%
Ikarian Capital, LLC 200,000$32,379,0002.62%
Soleus Capital Management, L.P. 103,114$16,693,0002.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 157,334$25,471,0002.47%
Capital Impact Advisors, LLC 45,440$7,356,0002.37%
ARK Investment Management 7,776,119$1,258,876,0002.34%
Sassicaia Capital Advisers LLC 13,513$2,188,0002.28%
View complete list of CRISPR THERAPEUTICS AG shareholders